A new study finds high rates of suicide among female nurses in the United States; President Joe Biden aims to undo Trump-era restrictions on abortion referrals; research indicates regular exercise may prevent severe COVID-19 outcomes.
A new study published in JAMA Psychiatry shows female nurses are 2 times as likely to die by suicide compared with females in the general population and 70% more likely compared with female physicians. Researchers conducted a retrospective cohort study and assessed US data from 2007 to 2018. In absolute terms, compared with the general population of US women, being a female nurse was associated with an additional 8.5 suicides per 100,000. The investigators stress future research is warranted to assess whether interventions could help reduce suicide risk among nurses.
President Joe Biden has begun to reverse a ban on clinics referring women for abortions implemented under former President Donald Trump, the Associated Press reports. The policy excluded Planned Parenthood from the federal family planning program and introduced new barriers for women trying to get birth control. Women’s groups had decried the measure as a “gag rule” while medical associations argued it violated the doctor-patient relationship. The Biden administration has not immediately suspended the regulation, as officials believe more deliberate, careful moves will increase chances proposed changes will be upheld in court.
Research published in the British Journal of Sports Medicine shows that among patients with COVID-19, those who were consistently inactive had a greater risk of hospitalization, admission to intensive care units, and death. In contrast, patients who consistently met physical activity guidelines had less severe COVID-19 outcomes. The study was conducted among 48,440 adult patients with a diagnosis between January and October 2020. Based on the findings, the researchers recommend public health agencies promote physical activity and incorporate recommendations into routine medical care.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More